• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒E7蛋白的羧基末端锌结合结构域可被E6蛋白的同源序列功能性取代。

The carboxyl-terminal zinc-binding domain of the human papillomavirus E7 protein can be functionally replaced by the homologous sequences of the E6 protein.

作者信息

Mavromatis K O, Jones D L, Mukherjee R, Yee C, Grace M, Münger K

机构信息

Laboratory of Tumor Virus Biology, National Cancer Institute, Bethesda, MD 20892, USA.

出版信息

Virus Res. 1997 Nov;52(1):109-18. doi: 10.1016/s0168-1702(97)00090-7.

DOI:10.1016/s0168-1702(97)00090-7
PMID:9453149
Abstract

The carboxyl-terminus is necessary for the functional and structural integrity of the human papillomavirus (HPV) E7 oncoprotein. Since many mutations in this domain of E7 result in the formation of unstable proteins, we have evaluated the importance of this region by replacing it with structurally related domains derived from HPV E6 proteins. Biological analysis of these mutant chimeric E7/E6 proteins showed that they retained E7-specific biological activities including cooperation with the ras oncogene to transform primary baby rat kidney cells and transcriptional activation of an E2F responsive reporter plasmid. One of the chimeric proteins was impaired in its ability to physically disrupt pRB/E2F complexes in vitro suggesting that there are defined molecular determinants in the carboxyl-terminus of E7 for this activity. In contrast, none of these proteins exhibited E6-like properties including binding to p53 and/or degradation of associated proteins.

摘要

羧基末端对于人乳头瘤病毒(HPV)E7癌蛋白的功能和结构完整性是必需的。由于E7这个结构域中的许多突变会导致不稳定蛋白质的形成,我们通过用源自HPV E6蛋白的结构相关结构域替换它,评估了该区域的重要性。对这些突变嵌合E7/E6蛋白的生物学分析表明,它们保留了E7特异性生物学活性,包括与ras癌基因协同转化原代新生大鼠肾细胞以及E2F反应性报告质粒的转录激活。其中一种嵌合蛋白在体外物理破坏pRB/E2F复合物的能力受损,这表明E7羧基末端存在决定该活性的特定分子决定因素。相比之下,这些蛋白均未表现出E6样特性,包括与p53结合和/或相关蛋白的降解。

相似文献

1
The carboxyl-terminal zinc-binding domain of the human papillomavirus E7 protein can be functionally replaced by the homologous sequences of the E6 protein.人乳头瘤病毒E7蛋白的羧基末端锌结合结构域可被E6蛋白的同源序列功能性取代。
Virus Res. 1997 Nov;52(1):109-18. doi: 10.1016/s0168-1702(97)00090-7.
2
Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.通过对人乳头瘤病毒E7进行共识预测平均法和光谱学研究,预测人乳头瘤病毒E7和E6蛋白锌结合基序的α-螺旋/β-折叠二级结构。
Biochem J. 1996 Oct 1;319 ( Pt 1)(Pt 1):229-39. doi: 10.1042/bj3190229.
3
Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.人乳头瘤病毒16型E6蛋白的突变分析:对人细胞的转化功能及体外p53降解
Virology. 1995 Oct 1;212(2):535-42. doi: 10.1006/viro.1995.1511.
4
A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.人乳头瘤病毒16型E7癌蛋白氨基末端结构域的突变分析。
Virology. 1994 Dec;205(2):603-7. doi: 10.1006/viro.1994.1688.
5
The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.人乳头瘤病毒6型和人乳头瘤病毒16型E7蛋白反式激活E2F反应元件的相对能力取决于启动子和细胞。
Virology. 1997 Dec 8;239(1):238-46. doi: 10.1006/viro.1997.8885.
6
Splice sites of human papillomavirus type 16 E6 gene or heterologous gene required for transformation by E7 and accumulation of E7 RNA.人乳头瘤病毒16型E6基因的剪接位点或E7转化及E7 RNA积累所需的异源基因。
J Med Virol. 1995 Dec;47(4):445-53. doi: 10.1002/jmv.1890470426.
7
Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.视网膜母细胞瘤蛋白的结合效率与人乳头瘤病毒E7癌蛋白的转化能力相关。
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4442-6. doi: 10.1073/pnas.89.10.4442.
8
Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses.由重组杆状病毒产生的16型人乳头瘤病毒E6、E7和L1蛋白以及18型E7蛋白。
J Virol Methods. 1993 Dec 31;45(3):303-18. doi: 10.1016/0166-0934(93)90115-8.
9
Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.人乳头瘤病毒31型E6和E7癌蛋白序列变异的系统发育和功能分析
Infect Genet Evol. 2016 Sep;43:94-100. doi: 10.1016/j.meegid.2016.05.020. Epub 2016 May 16.
10
Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.人乳头瘤病毒16型和棉尾兔乳头瘤病毒E7蛋白与视网膜母细胞瘤基因产物结合情况的比较
J Gen Virol. 1993 Jan;74 ( Pt 1):115-9. doi: 10.1099/0022-1317-74-1-115.

引用本文的文献

1
HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins.HIV-1蛋白酶抑制剂通过靶向清除病毒E6和E7癌蛋白减缓HPV16驱动的细胞增殖。
Cancers (Basel). 2021 Feb 24;13(5):949. doi: 10.3390/cancers13050949.
2
HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?人乳头瘤病毒癌蛋白与泛素蛋白酶体系统:恶性肿瘤的一种标志?
Pathogens. 2020 Feb 18;9(2):133. doi: 10.3390/pathogens9020133.
3
The human papillomavirus E7 oncoprotein as a regulator of transcription.
人乳头瘤病毒E7癌蛋白作为一种转录调节因子。
Virus Res. 2017 Mar 2;231:56-75. doi: 10.1016/j.virusres.2016.10.017. Epub 2016 Nov 8.
4
The papillomavirus E7 proteins.人乳头瘤病毒 E7 蛋白。
Virology. 2013 Oct;445(1-2):138-68. doi: 10.1016/j.virol.2013.04.013. Epub 2013 May 31.
5
Novel human gammapapillomavirus species in a nasal swab.鼻拭子中的新型人类γ乳头瘤病毒种类
Genome Announc. 2013 Mar 7;1(2):e0002213. doi: 10.1128/genomeA.00022-13.
6
Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins.视网膜母细胞瘤(pRB)口袋结构域的三个区域影响其被人乳头瘤病毒E7蛋白灭活的过程。
J Virol. 2002 Jun;76(12):6224-34. doi: 10.1128/jvi.76.12.6224-6234.2002.
7
Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.人乳头瘤病毒16型E7蛋白导致的视网膜母细胞瘤肿瘤抑制因子失稳不足以克服人角质形成细胞中的细胞周期停滞。
J Virol. 2001 Aug;75(15):6737-47. doi: 10.1128/JVI.75.15.6737-6747.2001.